Identification of two distinct pathways of protein kinase Calpha down-regulation in intestinal epithelial cells

Olga V Leontieva1, Jennifer D Black

  • 1Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

Insights

Protein kinase C alpha (PKCalpha) desensitization involves multiple pathways. This study identifies a novel ubiquitin/proteasome dependent pathway for PKCalpha down-regulation, distinct from internalization and dephosphorylation mechanisms.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Signal transduction

Background:

  • Signal transduction pathways rely on desensitization mechanisms affecting receptors and transducers.
  • Protein kinase C (PKC) family members, including PKCalpha, are known to down-regulate upon activation.
  • Prior research suggested PKCalpha desensitization involves caveolar internalization, dephosphorylation, ubiquitination, and proteasomal degradation.

Purpose of the Study:

  • To comparatively analyze PKCalpha processing induced by phorbol 12-myristate 13-acetate and bryostatin 1 in IEC-18 cells.
  • To identify and characterize distinct pathways of PKCalpha down-regulation.
  • To elucidate the role of ubiquitination, phosphorylation, and cellular trafficking in PKCalpha desensitization.

Main Methods:

  • Comparative analysis of PKCalpha processing using PKC agonists (phorbol 12-myristate 13-acetate, bryostatin 1).
  • Biochemical and morphological approaches in IEC-18 rat intestinal epithelial cells.
  • Utilized phosphatase inhibitors (okadaic acid, calyculin A) and inhibitors of vesicular trafficking.

Main Results:

  • Identified at least two co-existing pathways for PKCalpha down-regulation within cells.
  • Demonstrated that a single PKC agonist can activate both pathways simultaneously.
  • Characterized a novel ubiquitin/proteasome dependent pathway involving ubiquitination of activated PKCalpha at the plasma membrane.
  • Showed that this novel pathway does not require internalization or priming site dephosphorylation.
  • Indicated that caveolar trafficking and dephosphorylation are involved in a separate, proteasome-independent desensitization mechanism.

Conclusions:

  • PKCalpha desensitization can occur through at least two distinct pathways.
  • A novel pathway for PKCalpha down-regulation involves direct ubiquitination and proteasomal degradation of the activated enzyme at the plasma membrane.
  • Caveolar trafficking and dephosphorylation constitute a separate, proteasome-independent desensitization route.
  • Subcellular localization and phosphorylation status critically determine the PKCalpha desensitization pathway utilized.

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...